Clinical Trial Update: Concurrent Chemo-radiotherapy With Capecitabine for Unresectable Locally Advanced Pancreatic Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating concurrent chemoradiotherapy with capecitabine for unresectable locally advanced pancreatic cancer. The current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Capecitabine (capecitabine)

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Pancreatic Cancer | Phase 2 | Status: UNKNOWN